C-siPLK-1-NP

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameC-siPLK-1-NP

Drug Alias NameC-siPLK1-NPC-siPLK-1-NP

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate > Antibody-siRNA conjugateSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionPolo like kinase 1 inhibitorsRNA interference

TargetsPolo like kinase 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPdx Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesPdx Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A